Overview

Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab

Status:
Completed

Trial end date:
2009-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effects of anterior chamber paracentesis, brimonidine and oral acetazolamide to reduce intra-ocular pressure variations after intravitreal bevacizumab injection.

Phase:

Phase 2

Details

Lead Sponsor:

University of Sao Paulo

Collaborator:

Fundação de Apoio ao Ensino Pesquisa e Assitência do HCFMRPUSP

Treatments:

Acetazolamide
Bevacizumab
Brimonidine Tartrate